Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Vigabatrin on Insulin Sensitivity

NCT04321395 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04321395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04321395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Vigabatrin on Insulin Sensitivity
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
August 23, 2021
Completion date
May 15, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, obesity